Alder Biopharm (ALDR) PT Lowered to $27 at BMO Capital
Tweet Send to a Friend
BMO Capital lowered its price target on Alder Biopharm (NASDAQ: ALDR) to $27.00 (from $39.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
